Circle Pharma raises $45 Million in Series B Financing
Source: Circle Pharma March 17, 2020 South San Francisco, CA, March 17, 2020, — Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced that it has raised $45 million in a Series B financing. The financing was led by The Column Group, with participation by Nextech Invest. …